Literature DB >> 856877

Halothane macrophage migration inhibtiion factor test in halothane-associated hepatitis.

C D Price, A R Gibbs, W J Williams.   

Abstract

As an index of delayed hypersensitivity in vitro halothane macrophage migration inhibition factor tests (halothane-MIF tests) were performed on peripheral blood lymphocytes from five patients with halothane hepatitis. Twenty-two subjects exposed to halothane, but with no evidence of jaundice, five 'healthy' hospital anaesthetists, nine jaundiced subjects without halothane exposure, and 10 healthy subjects with no history of exposure to halothane were also tested. The halothane-MIF test was positive in four of the five patients with halothane-induced hepatitis; the negative result was in a patient on steroid treatment. The test was negative in all other subjects. Our findings suggest that the halothane-MIF test may be of value in the diagnosis of halothane-induced hepatitis and as a screeening procedure for the identification of susceptible subjects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856877      PMCID: PMC476402          DOI: 10.1136/jcp.30.4.312

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  POSTOPERATIVE HEPATIC NECROSIS. ITS INCIDENCE AND DIAGNOSTIC VALUE IN ASSOCIATION WITH THE ADMINISTRATION OF HALOTHANE.

Authors:  E M SLATER; J M GIBSON; M H DYKES; S G WALZER
Journal:  N Engl J Med       Date:  1964-05-07       Impact factor: 91.245

2.  Anesthetic, circulatory and respiratory effects of fluothane.

Authors:  T K BURNAP; S J GALLA; L D VANDAM
Journal:  Anesthesiology       Date:  1958 May-Jun       Impact factor: 7.892

3.  POSTOPERATIVE death after fluothane.

Authors: 
Journal:  Anesthesiology       Date:  1958 Jul-Aug       Impact factor: 7.892

Review 4.  Halothane hepatitis: a critical review.

Authors:  F M Carney; R A Van Dyke
Journal:  Anesth Analg       Date:  1972 Jan-Feb       Impact factor: 5.108

5.  Hepatic necrosis associated with halothane anesthesia.

Authors:  R L Peters; H A Edmondson; T B Reynolds; J C Meister; T J Curpey
Journal:  Am J Med       Date:  1969-11       Impact factor: 4.965

6.  Hepatitis after exposure to halothane.

Authors:  F M Klion; F Schaffner; H Popper
Journal:  Ann Intern Med       Date:  1969-09       Impact factor: 25.391

7.  Role of in vitro and in vivo tests of hypersensitivity in beryllium workers.

Authors:  C D Price; W J Williams; A Pugh; D H Joynson
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

8.  Jaundice after repeated exposure to halothane: an analysis of Reports to the Committee on Safety of Medicines.

Authors:  W H Inman; W W Mushin
Journal:  Br Med J       Date:  1974-01-05

9.  Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium.

Authors:  J Trowell; R Peto; A C Smith
Journal:  Lancet       Date:  1975-04-12       Impact factor: 79.321

10.  Controlled prospective study of the effect on liver function of multiple exposures to halothane.

Authors:  R Wright; O E Eade; M Chisholm; M Hawksley; B Lloyd; T M Moles; J C Edwards; M J GArdner
Journal:  Lancet       Date:  1975-04-12       Impact factor: 79.321

View more
  4 in total

Review 1.  Halothane and liver damage.

Authors:  D Rosenak; A Halevy; R Orda
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

Review 2.  Halothane anaesthesia and liver damage.

Authors:  J Neuberger; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-27

3.  Hepatic reactions to drugs.

Authors:  S Sherlock
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

4.  Characterization of a halothane-induced humoral immune response in rabbits.

Authors:  A H Callis; S D Brooks; T P Roth; A J Gandolfi; B R Brown
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.